“－－。、、．e。〔。b、、、”±±±－±、tx．－。．。be。～．－．。、±．－－。。－、±。－、a－l－、～Ｒ〕。al－－．。±．u±、。、、±、·。、－。·
834
2.2idit2004
=1.65P=0.103
2SASs
T2ComparisonofSASstandardscorebetweentwogroupsbeforeand
7
afterthetreatment
248
3071.16.360.33.953.54.140.42.7
3069.25.866.44.260.35.439.93.1
1.215.825.490.66
P0.230.000.000.50
SAS=
810
3n%
T3Comparisonofclinicaleffectsbetweentwogroups
301240.0026.671033.33620.00
301550.00930.00310.00310.00
2.3
1.J
4
2008161112461248.
2.35J
82
2010182145146.
3.
J201018121265
1266.
3
4.
J2012203404406.
5.CCMD3
M3.2001118119.
6.M.4.2002
GAD
627631.
7.M.
2009309.
16
8.
55
J2011204367
368.
9.
1720
J2013273208
212.
10.
J201032192917.
GADGAD
2013122120140127
GAD
|
|
